Detalhe da pesquisa
1.
Efficacy and safety of cotadutide, a dual glucagon-like peptide-1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease.
Diabetes Obes Metab
; 24(7): 1360-1369, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403793
2.
MEDI0382, a GLP-1/glucagon receptor dual agonist, meets safety and tolerability endpoints in a single-dose, healthy-subject, randomized, Phase 1 study.
Br J Clin Pharmacol
; 84(10): 2325-2335, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29926478
3.
End-stage heart failure with multiple intracardiac thrombi: a rescue strategy.
Tex Heart Inst J
; 31(4): 404-8, 2004.
Artigo
em Inglês
| MEDLINE | ID: mdl-15745293
4.
Recurrent in-stent restenosis is not associated with the angiotensin-converting enzyme D/I, angiotensinogen Thr174Met and Met235Thr, and the angiotensin-II receptor 1 A1166C polymorphism.
J Invasive Cardiol
; 19(6): 261-4, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17541127